실데나필 의약품 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 예상 성장은 제네릭 실데나필 제제의 수용 확대, 선진 지역의 폐동맥 고혈압 유병률 증가, 비용 효율적인 비뇨기과 치료에 대한 수요 증가, 그리고 관련 동반 질환을 가진 세계의 인구의 고령화 등에 의해 촉진될 것입니다. 예측 기간에 예상되는 주요 동향으로는 일반 의약품(OTC) 버전의 개발, 실데나필과 디지털 건강 솔루션의 번들링, 속용성 및 서방형 정제와 같은 제형 혁신, 여성 성기능 장애 연구에 대한 집중도 강화, 실데나필을 더 광범위한 남성 건강 제품 라인에 통합하는 등이 있습니다.
발기 부전의 유병률이 증가함에 따라 실데나필 의약품 시장의 성장이 촉진될 것으로 예상됩니다. 발기 부전은 성기능에 충분한 발기를 달성하거나 유지하는 데 지속적으로 또는 반복적으로 어려움을 겪는 상태입니다. 이러한 유병률의 증가는 주로 비만, 당뇨병, 심혈관 질환 등 혈류와 호르몬 수치에 영향을 미치는 생활 습관 관련 건강 문제 때문으로 보입니다. 실데나필은 음경으로의 혈류를 증가시켜 성기능을 개선하는 작용을 합니다. 이 약물은 빠른 작용과 비침습적인 해결책을 제공하여 발기 부전으로 고통받는 사람들의 자신감과 삶의 질을 향상시킵니다. 예를 들어, 2022년 1월 영국 기반 의료 서비스 제공업체인 ED 클리닉스는 40세에서 70세 사이 남성의 약 50-55%가 발기 부전을 경험하며, 이는 영국에서 약 430만 명에 해당한다고 보고했습니다.
실데나필 의약품 시장의 기업들은 사용자 경험을 개선하고 시장 도달 범위를 확대하기 위해 향이 첨가된 속용성 발기 부전(ED) 정제와 같은 첨단 약물 전달 시스템을 갖춘 혁신적인 제품 개발에 주력하고 있습니다. 이 정제는 빠르게 녹아 전통적인 ED 정제보다 더 discreet하고 편리한 대안을 제공하며, 맛을 개선하기 위해 향이 추가되었습니다. 예를 들어, 2023년 8월 미국 기반 건강 및 웰니스 기업인 Mangoceuticals, Inc.는 시알리스를 기반으로 한 ED 제품인 Mango를 출시했습니다. 이 제형은 시알리스와 옥시토신, L-아르기닌 등 독점 성분을 망고 향의 빠른 용해 정제에 결합해 빠른 효과 발현과 편의성을 추구했습니다. 이 제품은 비밀 유지가 가능하고 사용자 친화적인 경험을 제공하며, 안전한 원격 의료 플랫폼을 통해 상담 및 처방에 쉽게 접근할 수 있도록 배포됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 실데나필 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 실데나필 의약품 시장 : 성장률 분석
- 세계의 실데나필 의약품 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 실데나필 의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 실데나필 의약품 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 실데나필 의약품 시장 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 브랜드 의약품
- 제네릭 의약품
- 일반 의약품
- 세계의 실데나필 의약품 시장 제형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 정제
- 경구 현탁액
- 국소용 젤
- 주사제
- 세계의 실데나필 의약품 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 실데나필 의약품 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 발기 부전 치료
- 폐동맥성 고혈압(PAH)의 치료
- 기타 성기능 장애
- 적응 외 사용
- 세계의 실데나필 의약품 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 남성
- 여성
- 의료 종사자
- 세계의 실데나필 의약품 시장 : 브랜드 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 필름 코팅 제제
- 구강내 분산 필름
- 설하 스트립
- 츄어블 정제
- 세계의 실데나필 의약품 시장 : 제네릭 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 생물학적 동등성 제형
- 고정용량 배합제
- 실데나필의 복합 변이체
- 대체 염 형태
- 세계의 실데나필 의약품 시장 : 일반 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 허브와 실데나필 혼합
- 실데나필 기반 보충제
- 저용량 비처방약
- 성적 건강 콤보팩
제7장 지역별, 국가별 분석
- 세계의 실데나필 의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 실데나필 의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 실데나필 의약품 시장 : 경쟁 구도
- 실데나필 의약품 시장 : 기업 프로파일
- Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
- GSK plc : 개요, 제품 및 서비스, 전략 및 재무 분석
- Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Macleods Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Aurobindo Pharma Ltd.
- Hikma Pharmaceuticals plc
- Dr. Reddy's Laboratories Ltd.
- Cipla Ltd.
- Lupin Ltd.
- Zydus Lifesciences
- Hetero Drugs Ltd.
- Glenmark Pharmaceuticals Ltd.
- Alkem Laboratories Ltd.
- Torrent Pharmaceuticals Ltd.
- Jubilant Pharmova Limited
- Ajanta Pharma Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 실데나필 의약품 시장(2029년) : 새로운 기회를 제공하는 국가
- 실데나필 의약품 시장(2029년) : 새로운 기회를 제공하는 부문
- 실데나필 의약품 시장(2029년) : 성장 전략
제36장 부록
HBR
Sildenafil is a phosphodiesterase type 5 (PDE5) enzyme inhibitor primarily developed to relax blood vessels and enhance blood flow by amplifying the effects of nitric oxide. It is clinically used to treat erectile dysfunction and pulmonary arterial hypertension by promoting increased blood flow to specific tissues.
The main types of sildenafil drugs include branded drugs, generic drugs, and over-the-counter drugs. Branded sildenafil drugs are prescription medications marketed under a proprietary trade name, developed and patented by pharmaceutical companies. These medications are typically recognized for their guaranteed quality, clinical validation, and broad recognition. Sildenafil is available in various dosage forms, including tablets, oral suspension, topical gel, and injectable. It is distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Sildenafil is used for applications such as treating erectile dysfunction, pulmonary arterial hypertension (PAH), other sexual dysfunctions, and off-label uses. The end users of this drug include men, women, and healthcare professionals.
The sildenafil drug market research report is one of a series of new reports from The Business Research Company that provides sildenafil drug market statistics, including sildenafil drug industry global market size, regional shares, competitors with a sildenafil drug market share, detailed sildenafil drug market segments, market trends and opportunities, and any further data you may need to thrive in the sildenafil drug industry. This sildenafil drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sildenafil drug market size has grown strongly in recent years. It will grow from $3.39 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth observed during the historic period can be attributed to the rising prevalence of erectile dysfunction due to an aging population, increasing awareness and openness about men's sexual health, early marketing efforts aimed at lifestyle enhancement, regulatory approvals for treating pulmonary arterial hypertension, and growth in discretionary spending on wellness drugs.
The sildenafil drug market size is expected to see strong growth in the next few years. It will grow to $5.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The projected growth in the forecast period is driven by the increasing acceptance of generic sildenafil formulations, a rising prevalence of pulmonary arterial hypertension in developed regions, growing demand for cost-effective urology treatments, and the aging global population with associated comorbidities. Key trends expected in the forecast period include the development of over-the-counter (OTC) versions, bundling of sildenafil with digital health solutions, innovations in formulations such as fast-dissolving and extended-release tablets, a stronger focus on female sexual dysfunction research, and the integration of sildenafil into broader men's wellness product lines.
The increasing prevalence of erectile dysfunction is expected to drive the growth of the sildenafil drug market. Erectile dysfunction is a condition where individuals have consistent or recurrent difficulty in achieving or maintaining an erection sufficient for sexual performance. This rise in prevalence is largely attributed to lifestyle-related health issues that affect blood flow and hormone levels, such as obesity, diabetes, and cardiovascular disease. Sildenafil works by enhancing blood flow to the penis, improving sexual function. It offers a fast-acting, non-invasive solution, boosting confidence and quality of life for those affected by erectile dysfunction. For instance, in January 2022, the ED Clinics, a UK-based healthcare provider, reported that about 50-55% of men aged 40 to 70 experience erectile dysfunction, accounting for around 4.3 million men in the UK. Global estimates predict 322 million people will be affected by 2025. Therefore, the increasing prevalence of erectile dysfunction is fueling the growth of the sildenafil drug market.
Companies in the sildenafil drug market are focusing on developing innovative products with advanced drug delivery systems, such as flavored rapid-dissolve erectile dysfunction (ED) tablets, to improve user experience and expand their market reach. These tablets are designed to dissolve quickly, offering a discreet and convenient alternative to traditional ED tablets, with added flavors for better palatability. For example, in August 2023, Mangoceuticals, Inc., a US-based health and wellness company, launched a sildenafil-based ED product called Mango. This formulation combines sildenafil with proprietary compounds such as oxytocin and L-arginine in a mango-flavored, rapid-dissolve tablet, designed for faster onset and convenience. It offers a discreet, user-friendly experience and is distributed through a secure telemedicine platform for easy access to consultations and prescriptions.
In November 2023, Dare Bioscience Inc., a US-based biopharmaceutical company, extended its partnership with Premier Research International LLC to accelerate the clinical development of women's health drugs. This collaboration focuses on improving clinical trials, regulatory support, and the development of therapies for conditions such as female sexual arousal disorder, contraception, and vaginal health. Premier Research International LLC is a US-based contract research organization specializing in clinical development and regulatory support for biotech and pharmaceutical companies.
Major players in the sildenafil drug market are Pfizer Inc., Sanofi S.A., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Zydus Lifesciences, Hetero Drugs Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Jubilant Pharmova Limited, and Ajanta Pharma Ltd.
North America was the largest region in the sildenafil drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sildenafil drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sildenafil drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sildenafil drug market consists of sales of silofast effervescent formulations, sildenafil softgel capsules, sildenafil lozenges, oral thin films with buccal absorption, sildenafil nasal spray, liposomal sildenafil formulations, and sildenafil transdermal patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sildenafil Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sildenafil drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sildenafil drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sildenafil drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Branded Drugs; Generic Drugs; Over The Counter Drugs
- 2) By Dosage Form: Tablets; Oral Suspension; Topical Gel; Injectable
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
- 4) By Application: Erectile Dysfunction Treatment; Pulmonary Arterial Hypertension (PAH) Treatment; Other Sexual Dysfunction; Off-Label Uses
- 5) By End-User: Men; Women; Healthcare Professionals
- Subsegments:
- 1) By Branded Drugs: Film-Coated Formulations; Orodispersible Films; Sublingual Strips; Chewable Tablets
- 2) By Generic Drugs: Bioequivalent Formulations; Fixed-Dose Combinations; Compounded Sildenafil Variants; Alternate Salt Forms
- 3) By Over The Counter Drugs: Herbal-Sildenafil Blends; Sildenafil-Based Supplements; Low-Dose Non-Prescription Formulations; Sexual Wellness Combo Packs
- Companies Mentioned: Pfizer Inc.; Sanofi S.A.; GSK plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sildenafil Drug Market Characteristics
3. Sildenafil Drug Market Trends And Strategies
4. Sildenafil Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sildenafil Drug Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sildenafil Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sildenafil Drug Market Growth Rate Analysis
- 5.4. Global Sildenafil Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sildenafil Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sildenafil Drug Total Addressable Market (TAM)
6. Sildenafil Drug Market Segmentation
- 6.1. Global Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Branded Drugs
- Generic Drugs
- Over The Counter Drugs
- 6.2. Global Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Oral Suspension
- Topical Gel
- Injectable
- 6.3. Global Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- 6.4. Global Sildenafil Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Erectile Dysfunction Treatment
- Pulmonary Arterial Hypertension (PAH) Treatment
- Other Sexual Dysfunction
- Off-Label Uses
- 6.5. Global Sildenafil Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Men
- Women
- Healthcare Professionals
- 6.6. Global Sildenafil Drug Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Film-Coated Formulations
- Orodispersible Films
- Sublingual Strips
- Chewable Tablets
- 6.7. Global Sildenafil Drug Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioequivalent Formulations
- Fixed-Dose Combinations
- Compounded Sildenafil Variants
- Alternate Salt Forms
- 6.8. Global Sildenafil Drug Market, Sub-Segmentation Of Over The Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Herbal-Sildenafil Blends
- Sildenafil-Based Supplements
- Low-Dose Non-Prescription Formulations
- Sexual Wellness Combo Packs
7. Sildenafil Drug Market Regional And Country Analysis
- 7.1. Global Sildenafil Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sildenafil Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sildenafil Drug Market
- 8.1. Asia-Pacific Sildenafil Drug Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sildenafil Drug Market
- 9.1. China Sildenafil Drug Market Overview
- 9.2. China Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sildenafil Drug Market
- 10.1. India Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sildenafil Drug Market
- 11.1. Japan Sildenafil Drug Market Overview
- 11.2. Japan Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sildenafil Drug Market
- 12.1. Australia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sildenafil Drug Market
- 13.1. Indonesia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sildenafil Drug Market
- 14.1. South Korea Sildenafil Drug Market Overview
- 14.2. South Korea Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sildenafil Drug Market
- 15.1. Western Europe Sildenafil Drug Market Overview
- 15.2. Western Europe Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sildenafil Drug Market
- 16.1. UK Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sildenafil Drug Market
- 17.1. Germany Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sildenafil Drug Market
- 18.1. France Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sildenafil Drug Market
- 19.1. Italy Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sildenafil Drug Market
- 20.1. Spain Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sildenafil Drug Market
- 21.1. Eastern Europe Sildenafil Drug Market Overview
- 21.2. Eastern Europe Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sildenafil Drug Market
- 22.1. Russia Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sildenafil Drug Market
- 23.1. North America Sildenafil Drug Market Overview
- 23.2. North America Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sildenafil Drug Market
- 24.1. USA Sildenafil Drug Market Overview
- 24.2. USA Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sildenafil Drug Market
- 25.1. Canada Sildenafil Drug Market Overview
- 25.2. Canada Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sildenafil Drug Market
- 26.1. South America Sildenafil Drug Market Overview
- 26.2. South America Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sildenafil Drug Market
- 27.1. Brazil Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sildenafil Drug Market
- 28.1. Middle East Sildenafil Drug Market Overview
- 28.2. Middle East Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sildenafil Drug Market
- 29.1. Africa Sildenafil Drug Market Overview
- 29.2. Africa Sildenafil Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sildenafil Drug Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sildenafil Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sildenafil Drug Market Competitive Landscape And Company Profiles
- 30.1. Sildenafil Drug Market Competitive Landscape
- 30.2. Sildenafil Drug Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Sildenafil Drug Market Other Major And Innovative Companies
- 31.1. Macleods Pharmaceuticals Ltd.
- 31.2. Sun Pharmaceutical Industries Ltd.
- 31.3. Perrigo Company plc
- 31.4. Aurobindo Pharma Ltd.
- 31.5. Hikma Pharmaceuticals plc
- 31.6. Dr. Reddy's Laboratories Ltd.
- 31.7. Cipla Ltd.
- 31.8. Lupin Ltd.
- 31.9. Zydus Lifesciences
- 31.10. Hetero Drugs Ltd.
- 31.11. Glenmark Pharmaceuticals Ltd.
- 31.12. Alkem Laboratories Ltd.
- 31.13. Torrent Pharmaceuticals Ltd.
- 31.14. Jubilant Pharmova Limited
- 31.15. Ajanta Pharma Ltd.
32. Global Sildenafil Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sildenafil Drug Market
34. Recent Developments In The Sildenafil Drug Market
35. Sildenafil Drug Market High Potential Countries, Segments and Strategies
- 35.1 Sildenafil Drug Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sildenafil Drug Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sildenafil Drug Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
